Cells of the MPC-11 mouse myeloma cell line, which produces an IgG2b immunoglobulin, were subjected to mutagenesis with Melphalan or with ICR-191, after which they were cloned in soft agar. Approximately 0.5% of the clones produced altered heavy chains that: (i) were the same size as or larger than the parent; (ii) no longer were recognized by antibody specific for the parent -y2b subclass; (iii) were recognized by antibody specific for the -y2a subclass; (iv) were recognized by antibody against the Fab (NH2-terminal half) of the parental immunoglobulin, but lacked some of the antigenic determinants of the Fc (COOH-terminal half) of the heavy chain; (v) lacked many of the tryptic/chymotryptic peptides found in the parent; (vi) contained tryptic/chymotryptic peptides that were not present in the parent but were present in an unrelated y2a myeloma heavy chain; and (vii) assem- To study the genetic control of antibody synthesis, we have been examining a cultured line of mouse myeloma cells for variants that synthesize altered immunoglobulins. Variants that have lost the ability to synthesize heavy (H) chains occurred spontaneously at a rate of 10-8/cell per generation (1), but only after mutagenesis have we found variants that produce altered H chains. Some of these variants synthesized H chains that were smaller than those of the parent; these variants were discussed in a preceding paper (2). Here, we describe a group of variants that synthesize normal-sized or large H chains having serological, chemical, and assembly characteristics of a different subclass from the parent.
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MATERIALS AND METHODS
The cell line 45.6 and its subclones 45.6.2.4, 45.6.3.1, and 45.6.3.2 were derived from the MPC-11 mouse myeloma tumor, which produces an IgG2b immunoglobulin (3) . Maintenance of the cell cultures (2), mutagenesis with ICR-191 (2) or with Melphalan (4), and subsequent cloning in soft agar (5) Table 1 .
These variants fall into two groups: four synthesize H chains of normal (55,000 molecular weight) size, and one synthesizes an H chain of 75,000 molecular weight. The molecular weights were assigned according to the mobility of the chains in acrylamide gels containing sodium dodecyl sulfate.
Serological Analysis. Using Ouchterlony analysis with a variety of antisera, we compared variant H chains with the parental H chain ( Table 1) . As stated, none of these variant chains reacted with antibody specific for the 'y2b subclass of H chains were isolated by electrophoresis on acrylamide gels containing sodium dodecyl sulfate. The 3H-and "C-labeled chains were mixed; the proteins were freed of sodium dodecyl sulfate and then were digested by sequential additions of trypsin and chymotrypsin. The peptides were resolved on a cation exchange resin using a pyridine-acetate gradient. The details are noted in ref. 2 . Arrows mark differences in the profiles. the parent and all reacted with antibody specific for the y2a subclass. When the variants and the parent were compared using antibody against the Fc region of the MPC-11 protein, "spurs" of incomplete identity were seen, indicating that the variants lacked antigenic determinants present in the parent chain. An antiserum directed against the Fab region (NH2-terminal) of the MPC-11 protein failed to distinguish the The analysis also showed that the variant had many "new" peaks (arrows). To try to determine whether some of these latter peaks were specific for y2a chains, we carried out two other peptide analyses. First, the H chains of a y2a myeloma protein (LPC-1) were compared with the MPC-11 y2b H chain (Fig. lb) . Nonidentical peaks (arrows) would include presumptive 2a specific or variable (V) region components. Then the y2a variant H chain (M224) was compared with LPC-1 to see if any of these presumptive 2a specific or V region components were shared. Many were shared (see shaded peaks in Fig. lc) . Since the V regions of two nonrelated proteins such as LPC-1 and MPC-11 would be unlikely to account for all these shaded peaks, the conclusion is that the variant contains at least some y2a specific peptides.
However, until further structural analysis is done, one can only say that the variant M224 'y2a H chain has some peptides in common with another y2a protein (LPC-1) that are not contained in a -y2b (MPC-11) protein.
Peptide analysis has also shown that two -y2a variants, cytoplasmic lysates and analyzed on acrylamide gels containing sodium dodecyl sulfate (Fig. 3 ). In common with many IgG2. cells, the variant had little HL (8) . In addition, the variant assembled H2L2 more slowly than the parent.
DISCUSSION
In previous studies (1, 2, 4, 6, 9), we have shown that mutagenesis of an IgG2b-producing mouse myeloma cell line frequently gives rise to clones that have undergone a change in immunoglobulin production. Many of these variants produce heavy chains that differ from the parental heavy chains in their primary sequence. The heavy chains produced by the particular set of variants described above have serological and chemical characteristics of a heavy chain constant region that is different from the one expressed in the parent cells. We can only speculate on the mechanism by which a clone committed to the synthesis of a 'y2b H chain can give rise to a clone synthesizing a 'y2a H chain. There are two general types of mechanisms: (i) changes outside the gene coding for the parental H chain that affect its expression and (ii) mutations within the structural gene itself. One example of the former that we cannot exclude is the turning off of one gene and the turning on of another. Another example of a nonmutational event is a translocation (10) of the MPC-11 V region gene from the y2b constant region gene to the 'y2a constant region gene. However, if a strict translocation (10) were taking place, one would expect all the y2a variants to be identical; i.e., they would have the MPC-11 V region gene and a y2a constant region gene. In fact, they differ from each other by peptide analysis, by assembly patterns, and by size, thus excluding this possibility.
Contrasted to these possibilities are mechanisms involving changes within the structural genes for the 'y2b H chain.
Indeed, the variants do appear to be true mutants, since they arise as a result of mutagenesis, are stable, and synthesize an altered H chain. One possible mutational mechanism is mitotic crossing-over, equal or unequal, or some other sort of recombination between related tandem genes. (11) (12) (13) (14) . Another possible mechanism would be a deletion involving parts of two neighboring (,y2b and y2a) genes with the loss of termination of the MPC-11 (7y2b) constant region gene and a readthrough (14) into the adjoining -y2a constant region gene. With this mechanism, one would infer that the 'y2b and y2a genes are adjacent and ordered. This possibility could be tested by examining the polarity of the interconversions of these and other subclasses whose genes are closely linked.
We continue to consider why our variants of all types (those that synthesize no H chains, those synthesizing small H chains, and those synthesizing H chains of a different subclass) occur at such a high frequency and if these variants arise by the same or different mechanisms. Does the generation of variants relate in any way to the commitment of lymphocytes to the synthesis of a single immunoglobulin and the concomitant presence of unexpressed homologous genes? Is there any relationship of the incidence of variants to the genetics of a multi-gene system, the organization of the immunoglobulin genes, or to the generation of antibody diversity? The isolation of additional variants and structural studies of "mutant" proteins may help in the resolution of these questions. Fortunately, variants synthesizing y2a proteins of normal size secrete copious amounts of these proteins into the serum of tumor-bearing animals, thus facilitating their chemical characterization.
